Visseren FLJ, Mach F, Smulders YM et al (2021) 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 42:3227–3337

Article  PubMed  Google Scholar 

Cardiovascular disease: risk assessment and reduction, including lipid modification NICE guideline Published: 14 December 2023 www.nice.org.uk/guidance/ng238

Reiter-Brennan C, Osei AD, Iftekhar Uddin SMI, Orimoloye OA, Obisesan OH, Mirbolouk M, Blaha MJ, Dzaye O (2020) ACC/AHA lipid guidelines: personalized care to prevent cardiovascular disease. Cleve Clin J Med 87:231–239

Article  PubMed  Google Scholar 

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Lochen ML, Lollgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S, ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37:23152381

Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT; ESC Scientific Document Group. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 37:2999-3058

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESC Scientific Document Group (2020) 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111–188

Article  PubMed  Google Scholar 

Katzmann JL, Kieble M, Enners S, Böhm M, Mahfoud F, Laufs U, Schulz M (2022) Trends in ezetimibe prescriptions as monotherapy or fixed-dose combination in Germany 2012–2021. Front Cardiovasc Med 9:912785

Article  PubMed  PubMed Central  CAS  Google Scholar 

Katzmann JL, Sorio-Vilela F, Dornstauder E, Fraas U, Smieszek T, Zappacosta S, Laufs U (2022) Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C. Clin Res Cardiol 111:243–252

Article  PubMed  CAS  Google Scholar 

Stang A, Merrill RM, Kuß O (2011) Nationwide rates of conversion from laparoscopic or vaginal hysterectomy to open abdominal hysterectomy in Germany. Eur J Epidemiol 26:125–133

Article  PubMed  Google Scholar 

Stang A, Kääb-Sanyal V, Hense HW, Becker N, Kuss O (2013) Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005–2009. Eur J Epidemiol 28:689–696

Article  PubMed  Google Scholar 

Danese M, Sidelnikov E, Villa G, Catterick D, Iqbal M, Gleeson M, Lubeck D, Patel J (2022) Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK. BMJ Open 12:e055015

Article  PubMed  PubMed Central  Google Scholar 

Sabouret P, Puymirat E, Kownator S, Abdennbi K, Lebeau F, Meltz M, Angoulvant D, Schiele F (2023) Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practice. Panminerva Med 65:244–249

Article  PubMed  Google Scholar 

Schubert J, Lindahl B, Melhus H, Renlund H, Leosdottir M, Yari Ai, Ueda P, Jernberg T, Hagström E (2021) Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study. Eur Heart J 42(3):243–252

Article  PubMed  CAS  Google Scholar 

Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, Murphy J, Banach M, De Servi S, Gaita D, Gouni-Berthold I, Hovingh GK, Jozwiak JJ, Jukema JW, Kiss RG, Kownator S, Iversen HK, Maher V, Masana L, Parkhomenko A, Peeters A, Clifford P, Raslova K, Siostrzonek P, Romeo S, Tousoulis D, Vlachopoulos C, Vrablik M, Catapano AL, Poulter NR, DA VINCI study (2021) EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study. Eur J Prev Cardiol 28:1279–1289

Article  PubMed  Google Scholar 

Cannon CP, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Gao Q, Palagashvilli T, Alam S, Mues KE, Bhatt DL, Kosiborod MN; GOULD Investigators (2021) Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US. JAMA Cardiol 6(9):1060–1068

Landmesser U, Pirillo A, Farnier M, Jukema JW, Laufs U, Mach F, Masana L, Pedersen TR, Schiele F, Steg G, Tubaro M, Zaman A, Zamorano P, Catapano AL (2020) Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: the ACS patient pathway project. Atheroscler Suppl 42:e49-58

Article  PubMed  Google Scholar 

Burkhardt T, Scherer M, Scherer G, Pluym N, Weber T, MarikeKolossa-Gehring M (2023) Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany - showcases for successful European legislation. Environ Res 216:114638

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stival C, Lugo A, Odone A, van den Brandt PA, Fernandez E, Tigova O, Soriano JB, López MJ, Scaglioni S, Gallus S (2022) TackSHS project investigators prevalence and correlates of overweight and obesity in 12 European countries in 2017-2018. Obes Facts 15:655–665

Article  PubMed  PubMed Central  Google Scholar 

Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, Braunwald E, Giugliano RP, Sabatine MS (2020) Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet 396(10263):1637–1643

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sato T, Minami Y, Asakura K, Katamine M, Kato A, Katsura A, Muramatsu Y, Kakizaki R, Nemoto T, Hashimoto T, Fujiyoshi K, Kameda R, Meguro K, Shimohama T, Ako J (2020) Age- and gender-related differences in coronary lesion plaque composition on optical coherence tomography. Circ J 84:463–470

Article  PubMed  CAS  Google Scholar 

Suzuki K, Niida T, Yuki H, Kinoshita D, Fujimoto D, Lee H, McNulty I, Takano M, Nakamura S, Kakuta T, Mizuno K, Jang IK (2023) Coronary plaque characteristics and underlying mechanism of acute coronary syndromes in different age groups of patients with diabetes. J Am Heart Assoc 12:e031474

Article  PubMed  PubMed Central  Google Scholar 

Nedkoff L, Lopez D, Hung J, Knuiman M, Briffa TG, Murray K, Davis E, Aria S, Robinson K, Beilby J, Hobbs MST, Sanfilippo FM (2022) Validation of ICD-10-AM coding for myocardial infarction subtype in hospitalisation data. Heart Lung Circ 31:849–858

Article  PubMed  Google Scholar 

Koenig W, Lorenz ES, Beier L, Gouni-Berthold I (2024) Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany. Clin Res Cardiol 113:812–821

Article  PubMed  CAS  Google Scholar